Visby Medical
PrivateLast Round
Early Funding
Jun 17, 2025
Est. Valuation
$1B
Total Funding Raised
$356.47M
Company Overview
Visby Medical is a diagnostics company that develops single-use handheld PCR-based testing kits for the detection of infectious diseases, including sexual and respiratory health tests.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Telemedicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Visby Medical Comparables
Compare Visby Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aptitude Medical | 81% | |
| binx health | 81% | |
| Co-Diagnostics, Inc. | 78% |
Visby Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 17, 2025 | ||||
| Grant | Jan 15, 2025 | ||||
| Grant | Oct 1, 2023 | ||||
| Series E Extension | Jun 29, 2022 | ||||
| Grant | Mar 25, 2022 | ||||
Grant | Feb 2, 2021 |
Visby Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) | Grant |
| J Ventures | Series E Extension, Grant |
| CARB-X | Grant |
| Healthcare of Ontario Pension Plan | Grant |
| NIH RADx | Grant |
| +ND Capital | Early Funding, Grant |
| J Ventures | Series E Extension, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
Developing at-home respiratory pathogen detection tests with Watchmaker Genomics.
- Feb 5, 2026
Partnered with Watchmaker Genomics for at-home respiratory tests.
Recent news
Latest coverage and updates
- partners_withJul 2, 2026
Visby Medical, Inc. partnered with LabCorp on Jul 1st '25.
- partners_withJul 2, 2026
Visby Medical, Inc. partnered with Quest Diagnostics Incorporated on Jul 1st '25.
Visby Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Visby Medical's valuation, stock price, and market status.
Is Visby Medical a public or private company?
Visby Medical is a private company.
What is the current stock price of Visby Medical?
Visby Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Visby Medical worth (valuation)?
Visby Medical's valuation is estimated at $1.0B based on funding round data.
Can I buy Visby Medical stock?
Visby Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Visby Medical's last funding round?
Visby Medical's most recent funding round was Early Funding on June 29, 2022.
Who are the main investors in Visby Medical?
Key investors in Visby Medical include CARB-X, Healthcare of Ontario Pension Plan, NIH RADx, Catalio Capital Management, Public Health Emergency Medical Countermeasures Enterprise.
Will Visby Medical IPO soon?
No public IPO plans have been announced for Visby Medical.
How can I track Visby Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Visby Medical's secondary market activity and sign up for updates.